NRC Health
NRC
NASDAQ·Healthcare·Medical - Healthcare Information Services·Mkt cap $485.2M
$21.53
▲ +1.32%
P/E
82.05
Mkt Cap
$485.2M
52-Wk Range
$11.01–$23.68
52-Week Range
$11.01 - $23.68
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 36.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
6 reasons
- 40+ years of healthcare analytics expertise and established market presence
- Comprehensive, integrated platform addressing multiple mission-critical healthcare functions
- Subscription-based recurring revenue model with high customer retention
- Deep relationships with integrated health systems, post-acute providers, and payers
- Proprietary data and benchmarking capabilities across U.S. and Canadian markets
- Real-time competitive assessment and segmentation tools for strategic decision-making
Bear Case
2 risks
- Low volatility (beta 0.4).
- Premium valuation to Healthcare IT & Services peers
Growth
Revenue decline expected
Increasing healthcare focus on patient experience and satisfaction metrics
Value
Premium valuation to Healthcare IT & Services peers
Momentum
Strong
+11.4% over 3m
Quality
Excellent
Strong fundamentals
Dividend
Solid
2.79% yield
Smart-money signal
Who's buying NRC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 26, 2026
JUL 28, 2026
Reported EPS of $0.31 vs -$0.15 consensus (+306.7% surprise). Revenue of $35.4M vs $34.9M expected (+1.4%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+306.7%
Revenue trend · last 8Q
—
-3%
-5%
-3%
-3%
-5%
+4%
+4%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$35.8M
$36.9M
$33.6M
$34.0M
$34.6M
$35.2M
$34.8M
$35.4M
Margins · last 8Q
Gross
0.0%
Operating
-9.2%
Profit
-9.3%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Citi · Jul 29, 2026
vs Industry
How NRC stacks vs Medical - Healthcare Information Services
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related